Dr. Monzon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5008 Crawford St
Houston, TX 77004Phone+1 281-888-8231- Is this information wrong?
Education & Training
- UPMC Medical EducationFellowship, Molecular Genetic Pathology, 2002 - 2003
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Pathology-Anatomic and Clinical, 1998 - 2002
- Universidad Nacional Autonoma de MexicoClass of 1992
Certifications & Licensure
- AZ State Medical License 2017 - 2026
- CA State Medical License 2014 - 2025
- TX State Medical License 2008 - 2024
- PA State Medical License 2002 - 2018
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- 3 citationsAnalytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.Sherri Borman, Jeff Wilkinson, Lauren Meldi-Sholl, Clare Johnson, Kelsey Carter, Kyle R Covington, Alison L Fitzgerald, Sarah J Kurley, Aaron S Farberg, Matthew S Gold...> ;Diagnostic Pathology. 2022 Feb 25
- 17 citationsIntegrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.Eric D. Whitman, Vadim P. Koshenkov, Brian R. Gastman, Deri Lewis, Eddy C. Hsueh, Ho Pak, Thomas P. Trezona, Robert S. Davidson, Michael McPhee, J. Michael Guenther, P...> ;JCO Precision Oncology. 2021 Sep 13
- 9 citationsSentinel lymph node biopsy in melanoma: beyond histologic factorsMichael J Carr, Federico A. Monzon, Jonathan S. Zager> ;Clinical & Experimental Metastasis. 2021 Jun 8
- Join now to see all
Press Mentions
- Castle Biosciences Presents Data on DecisionDxNovember 12th, 2020
- Castle Biosciences to Present Data at the American Society of Dermatopathology (ASDP) 57th Virtual Annual MeetingOctober 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: